OpASHA Improving Tuberculosis Treatment and Outcomes
Tuberculosis (TB) afflicts 2.8 million citizens in India, representing more than 30 percent of the world's total burden. To control TB, complete adherence to treatment is crucial-under the World Health Organization's (WHO) Directly Observed Therapy Short-course (DOTS) strategy. In this str...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Washington, D.C
The World Bank
2017
|
| Schriftenreihe: | Other papers
|
| Online-Zugang: | BSB01 FHI01 HTW01 EUV01 IOS01 URL des Erstveröffentlichers |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV048268229 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 220609s2017 |||| o||u| ||||||eng d | ||
| 024 | 7 | |a 10.1596/27665 |2 doi | |
| 035 | |a (ZDB-1-WBA)NLM010454470 | ||
| 035 | |a (OCoLC)1334048205 | ||
| 035 | |a (DE-599)GBVNLM010454470 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-573 |a DE-523 |a DE-521 |a DE-Re13 | ||
| 100 | 1 | |a Agapitova, Natalia |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a OpASHA |b Improving Tuberculosis Treatment and Outcomes |c Natalia Agapitova |
| 264 | 1 | |a Washington, D.C |b The World Bank |c 2017 | |
| 300 | |a 1 Online-Ressource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Other papers | |
| 520 | |a Tuberculosis (TB) afflicts 2.8 million citizens in India, representing more than 30 percent of the world's total burden. To control TB, complete adherence to treatment is crucial-under the World Health Organization's (WHO) Directly Observed Therapy Short-course (DOTS) strategy. In this strategy, patients are required to take up to 75 doses under supervision over six months at a treatment center or in the presence of an observer. However, the scarcity or inaccessibility of treatment centers and truthful observers in hard to-reach areas often results in high default rates. Missing a dose or interrupting treatment is extremely dangerous, since those who default can relapse, or much worse, develop the deadlier, drug-resistant strain of TB. A continuing social stigma for those who have TB is also linked to incomplete treatment and lack of follow-up. There is poor data collection as well. Since 2006, Operation ASHA (OpASHA) has helped deliver the Last-mile connection to TB treatment and prevention in India by leveraging existing government infrastructure to supplement the country's own efforts. OpASHA receives free medicines, diagnostic facilities and physician services from the national TB control program. Through a partnership with Microsoft Research, OpASHA has pioneered a biometric technology called eCompliance for treatment. OpASHA serves 10 million people in nine states across India, in addition to 2.2 million people in Cambodia. OpASHA has expanded to Cambodia, and its model has already been replicated in Uganda, Kenya, and the Dominican Republic | ||
| 700 | 1 | |a Agapitova, Natalia |4 oth | |
| 700 | 1 | |a Navarrete Moreno, Cristina |4 oth | |
| 856 | 4 | 0 | |u http://elibrary.worldbank.org/doi/book/10.1596/27665 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-1-WBA | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-033648424 | ||
| 966 | e | |u http://elibrary.worldbank.org/doi/book/10.1596/27665 |l BSB01 |p ZDB-1-WBA |x Verlag |3 Volltext | |
| 966 | e | |u http://elibrary.worldbank.org/doi/book/10.1596/27665 |l FHI01 |p ZDB-1-WBA |x Verlag |3 Volltext | |
| 966 | e | |u http://elibrary.worldbank.org/doi/book/10.1596/27665 |l HTW01 |p ZDB-1-WBA |x Verlag |3 Volltext | |
| 966 | e | |u http://elibrary.worldbank.org/doi/book/10.1596/27665 |l EUV01 |p ZDB-1-WBA |x Verlag |3 Volltext | |
| 966 | e | |u http://elibrary.worldbank.org/doi/book/10.1596/27665 |l IOS01 |p ZDB-1-WBA |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804184079373959168 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Agapitova, Natalia |
| author_facet | Agapitova, Natalia |
| author_role | aut |
| author_sort | Agapitova, Natalia |
| author_variant | n a na |
| building | Verbundindex |
| bvnumber | BV048268229 |
| collection | ZDB-1-WBA |
| ctrlnum | (ZDB-1-WBA)NLM010454470 (OCoLC)1334048205 (DE-599)GBVNLM010454470 |
| discipline | Wirtschaftswissenschaften |
| discipline_str_mv | Wirtschaftswissenschaften |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03184nmm a2200397zc 4500</leader><controlfield tag="001">BV048268229</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">220609s2017 |||| o||u| ||||||eng d</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1596/27665</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-1-WBA)NLM010454470</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1334048205</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)GBVNLM010454470</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-573</subfield><subfield code="a">DE-523</subfield><subfield code="a">DE-521</subfield><subfield code="a">DE-Re13</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Agapitova, Natalia</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">OpASHA</subfield><subfield code="b">Improving Tuberculosis Treatment and Outcomes</subfield><subfield code="c">Natalia Agapitova</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C</subfield><subfield code="b">The World Bank</subfield><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Other papers</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Tuberculosis (TB) afflicts 2.8 million citizens in India, representing more than 30 percent of the world's total burden. To control TB, complete adherence to treatment is crucial-under the World Health Organization's (WHO) Directly Observed Therapy Short-course (DOTS) strategy. In this strategy, patients are required to take up to 75 doses under supervision over six months at a treatment center or in the presence of an observer. However, the scarcity or inaccessibility of treatment centers and truthful observers in hard to-reach areas often results in high default rates. Missing a dose or interrupting treatment is extremely dangerous, since those who default can relapse, or much worse, develop the deadlier, drug-resistant strain of TB. A continuing social stigma for those who have TB is also linked to incomplete treatment and lack of follow-up. There is poor data collection as well. Since 2006, Operation ASHA (OpASHA) has helped deliver the Last-mile connection to TB treatment and prevention in India by leveraging existing government infrastructure to supplement the country's own efforts. OpASHA receives free medicines, diagnostic facilities and physician services from the national TB control program. Through a partnership with Microsoft Research, OpASHA has pioneered a biometric technology called eCompliance for treatment. OpASHA serves 10 million people in nine states across India, in addition to 2.2 million people in Cambodia. OpASHA has expanded to Cambodia, and its model has already been replicated in Uganda, Kenya, and the Dominican Republic</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Agapitova, Natalia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Navarrete Moreno, Cristina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://elibrary.worldbank.org/doi/book/10.1596/27665</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-WBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-033648424</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://elibrary.worldbank.org/doi/book/10.1596/27665</subfield><subfield code="l">BSB01</subfield><subfield code="p">ZDB-1-WBA</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://elibrary.worldbank.org/doi/book/10.1596/27665</subfield><subfield code="l">FHI01</subfield><subfield code="p">ZDB-1-WBA</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://elibrary.worldbank.org/doi/book/10.1596/27665</subfield><subfield code="l">HTW01</subfield><subfield code="p">ZDB-1-WBA</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://elibrary.worldbank.org/doi/book/10.1596/27665</subfield><subfield code="l">EUV01</subfield><subfield code="p">ZDB-1-WBA</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://elibrary.worldbank.org/doi/book/10.1596/27665</subfield><subfield code="l">IOS01</subfield><subfield code="p">ZDB-1-WBA</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV048268229 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T19:59:58Z |
| indexdate | 2024-07-10T09:33:38Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-033648424 |
| oclc_num | 1334048205 |
| open_access_boolean | |
| owner | DE-12 DE-573 DE-523 DE-521 DE-Re13 DE-BY-UBR |
| owner_facet | DE-12 DE-573 DE-523 DE-521 DE-Re13 DE-BY-UBR |
| physical | 1 Online-Ressource |
| psigel | ZDB-1-WBA |
| publishDate | 2017 |
| publishDateSearch | 2017 |
| publishDateSort | 2017 |
| publisher | The World Bank |
| record_format | marc |
| series2 | Other papers |
| spelling | Agapitova, Natalia Verfasser aut OpASHA Improving Tuberculosis Treatment and Outcomes Natalia Agapitova Washington, D.C The World Bank 2017 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Other papers Tuberculosis (TB) afflicts 2.8 million citizens in India, representing more than 30 percent of the world's total burden. To control TB, complete adherence to treatment is crucial-under the World Health Organization's (WHO) Directly Observed Therapy Short-course (DOTS) strategy. In this strategy, patients are required to take up to 75 doses under supervision over six months at a treatment center or in the presence of an observer. However, the scarcity or inaccessibility of treatment centers and truthful observers in hard to-reach areas often results in high default rates. Missing a dose or interrupting treatment is extremely dangerous, since those who default can relapse, or much worse, develop the deadlier, drug-resistant strain of TB. A continuing social stigma for those who have TB is also linked to incomplete treatment and lack of follow-up. There is poor data collection as well. Since 2006, Operation ASHA (OpASHA) has helped deliver the Last-mile connection to TB treatment and prevention in India by leveraging existing government infrastructure to supplement the country's own efforts. OpASHA receives free medicines, diagnostic facilities and physician services from the national TB control program. Through a partnership with Microsoft Research, OpASHA has pioneered a biometric technology called eCompliance for treatment. OpASHA serves 10 million people in nine states across India, in addition to 2.2 million people in Cambodia. OpASHA has expanded to Cambodia, and its model has already been replicated in Uganda, Kenya, and the Dominican Republic Agapitova, Natalia oth Navarrete Moreno, Cristina oth http://elibrary.worldbank.org/doi/book/10.1596/27665 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Agapitova, Natalia OpASHA Improving Tuberculosis Treatment and Outcomes |
| title | OpASHA Improving Tuberculosis Treatment and Outcomes |
| title_auth | OpASHA Improving Tuberculosis Treatment and Outcomes |
| title_exact_search | OpASHA Improving Tuberculosis Treatment and Outcomes |
| title_exact_search_txtP | OpASHA Improving Tuberculosis Treatment and Outcomes |
| title_full | OpASHA Improving Tuberculosis Treatment and Outcomes Natalia Agapitova |
| title_fullStr | OpASHA Improving Tuberculosis Treatment and Outcomes Natalia Agapitova |
| title_full_unstemmed | OpASHA Improving Tuberculosis Treatment and Outcomes Natalia Agapitova |
| title_short | OpASHA |
| title_sort | opasha improving tuberculosis treatment and outcomes |
| title_sub | Improving Tuberculosis Treatment and Outcomes |
| url | http://elibrary.worldbank.org/doi/book/10.1596/27665 |
| work_keys_str_mv | AT agapitovanatalia opashaimprovingtuberculosistreatmentandoutcomes AT navarretemorenocristina opashaimprovingtuberculosistreatmentandoutcomes |